SCHEMBL27997101

SCHEMBL27997101

COc1cc(F)cc(F)c1-c1nc(C)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 2/20 0.40
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ FFAR1 O14842 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ PDE2A O00408 2/20 0.35
▸ PDE10A Q9Y233 2/20 0.35
▸ CRHR1 P34998 3/20 0.35
▸ NSD2 O96028 1/20 0.35
▸ G6PD P11413 1/20 0.35
▸ DNMT1 P26358 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ SYK P43405 3/20 0.34
▸ AURKB Q96GD4 2/20 0.34
▸ INCENP Q9NQS7 2/20 0.34
▸ TRPA1 O75762 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19240430 0.79 S1PR4 (0.34) MAPT
SCHEMBL1711752 0.79 TGFBR1 (0.38) TGFBR1CYP3A4CYP2C8PAX8CRHR1
SCHEMBL31262781 0.72 KDM4E (0.42) NSD2KDM4EALDH1A1
SCHEMBL1711384 0.71 S100A4 (0.38) TGFBR1FFAR1RAB9AADORA1
SCHEMBL13738009 0.70 CCR1 (0.46) PDE2APDE10AMAPTRAB9AADORA1
SCHEMBL318842 0.70 CCR1 (0.38) TGFBR1CYP3A4CYP2C8PDE2APDE10A
SCHEMBL10086105 0.68 TUBB1 (0.42) CYP3A4FFAR1TRPA1LMNAMAPT
SCHEMBL31262598 0.67 TDP1 (0.40) CYP3A4KDM4EALDH1A1LMNAMAPT
SCHEMBL31262419 0.67 TRPA1 (0.39) CYP3A4KCNH2TRPA1NPC1ALDH1A1
SCHEMBL13086666 0.67 TUBB1 (0.39) CYP3A4PDE2APDE10ATRPA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104311480-A Picolinamide derivatives as kinase inhibitors NOVARTIS AG 2015-01-28 — — CN disclosed
Send feedback